-Reuters Abbott Laboratories Inc has instructed its sales representatives in India not to give gifts to doctors, a practice that has been used as a bargaining chip by companies wanting a piece of the country’s burgeoning healthcare market. According to an internal email dated October 11 from Sudarshan Jain, managing director of Abbott Healthcare Pvt. Ltd, the gift-giving has been temporarily suspended. “Only Abbott-approved clinical/scientific literature may be distributed to current and potential...
More »SEARCH RESULT
Health ministry pushes for end to sale of branded Drugs -Kounteya Sinha
-The Times of India Medicines in India may not be sold under brand names in the near future. In its biggest move to push generic Drugs and do away with brand names, the Union health ministry has ordered states to stop issuing licence for the manufacture or sale of Drugs on the basis of their brand name. All pharmaceutical firms applying for licence to market or manufacture fixed dose combination (FDC) Drugs will...
More »Small infections cost Indians Rs 69,000 crore a year -Pratibha Masand
-The Times of India India loses Rs 69,000 crore a year—more than twice the sum of Rs 34,488 crore it set aside for the country's health budget in 2012—to small infections. What's more, an estimated 38 crore of its citizens catch small infections with the result that they lose 162 crore workdays every year. This is the shocking finding of a recent London School of Economics study that puts a question mark...
More »Must poor fast to buy Drugs: SC -Dhananjay Mahapatra
-The Times of India The Centre on Thursday promised to notify a new drug pricing mechanism for essential medicines by the end of November, but the Supreme Court said a change in policy must not force a sharp rise in drug prices to hurt an already hassled common man. Additional solicitor general Siddharth Luthra informed a bench of Justices G S Singhvi and S J Mukhopadhaya that a Cabinet note on the...
More »SC gives govt time till Nov 27 for final drug pricing policy -Utkarsh Anand
-The Indian Express The Supreme Court on Thursday gave one month’s time to the Centre to come up with the final version of the drug pricing policy. Maintaining that the Centre must follow a pricing formula that will prevent the prices of the Drugs from shooting up, the SC agreed to wait till mid-November for the Cabinet to come up with its final version of the new pricing policy. “Drugs prescribed by doctors......
More »